Editor's note:Check out this week's roundup of Houston's top innovation news. InnovationMap's Houston technology and startup trends articles included can't-miss events this month, a guest column with business trends predictions, and more.
Houston immuno-oncology company reaches next FDA milestone, heading into Phase 2 clinical trial
A promising Houston immuno-oncology company is one step closer to bringing cancer drugs to patients who need them. Photo from Getty Images
The Houston immuno-oncology company recently made significant progress in negotiations with the FDA, including fast track and orphan drug designations. The company will soon begin a Phase 2 trial of its promising cancer-fighting innovation.
Diakonos Oncology was born in 2016 as the brainchild of Baylor researchers already working hard in the field of dendritic cell vaccines. Doctors. Will Decker, Matt Halpert and Vanaja Konduri partnered with Houston businessman and pharmacist Dan Faust to bring their treatment to the public, Chief Operating Officer Jay said.・Mr. Hartenbach says.
The name Diakonos means “deacon or servant in Greek,” he explains. “Many companies end up focusing on treating specific diseases or cancers, and the end result has great potential, but also comes with many trade-offs and downsides. So our goal is that we need to remove the cancer, but in doing so we can't harm or dramatically adversely affect the patient.” Keep reading.
Houston startup with unique vascular innovation enrolls subjects in new trial
VenoStent's innovative medical device has officially enrolled subjects in a clinical trial. Image courtesy of VenoStent
The Houston-based company has enrolled its first subjects in the first-of-its-kind trial.
VenoStent was created to improve vascular surgical outcomes for patients undergoing arteriovenous fistula (AVF) creation surgery.
“When a vein is connected to an artery, as in an AVF creation, the vein experiences a 10-fold increase in pressure and flow, which shocks the vein, much of which cannot be used for dialysis,” said VenoStent COO and co-founder. said Jeffrey Lux in a news release. Keep reading.
Houston experts share 3 business trend predictions for 2024
Here are our predictions for current and emerging trends that will further shape business in 2024. Photo from Getty Images
Last year was a dynamic year for companies across all sectors. Artificial intelligence has gone from being a new technology to a more widely used business productivity tool. Many companies have invested additional resources in sustainable business practices. And digital business solutions helped companies grow.
Here are our predictions for current and emerging trends that will further shape business in 2024. Keep reading.
Rice provides federal funding for new 5G testing framework
This project will focus on testing 5G networks for software-centric architectures.Photo from Getty Images
A team of Rice University engineers has won a $1.9 million grant from the U.S. Department of Commerce's National Telecommunications and Information Administration to develop a new way to test 5G networks.
The project will focus on testing 5G networks for software-centric architectures, Rice said in a statement. The funding comes from NTIA's latest grants totaling approximately $80 million as part of the $1.5 billion Public Wireless Supply Chain Innovation Fund. Other award winners included Virginia Tech, Northeastern University and DISH Wireless.
The Rice University project will be led by Rahman Doost Mohammadi, assistant professor of electrical and computer engineering. and Ashutosh Sabharwal, Ernest Del Butcher Professor of Engineering and chair of the Department of Electrical and Computer Engineering. Santiago Segarra, assistant professor of electrical and computer engineering and expert in machine learning for wireless network design, is also a co-principal investigator on the project. Keep reading.
